LAJIN ENT (08172) Receives Letter from Stock Exchange
Stock News
Aug 18
LAJIN ENT (08172) announced that on August 15, 2025, the company received a letter from the Stock Exchange notifying the company of its decision that, pursuant to GEM Listing Rule 17.26, the company has failed to maintain a sufficient level of operations and assets of considerable value to support its operations to warrant the continued listing of its shares. Unless the company exercises its right to apply for a review of this decision under Chapter 4 of the GEM Listing Rules, the company's shares will be suspended from trading on August 27, 2025 pursuant to GEM Listing Rule 9.04(3).
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.